Bill Text: NY A09020 | 2023-2024 | General Assembly | Amended

---

Bill Title: Directs the commissioner of health to establish a blood clot and pulmonary embolism policy workgroup.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced) 2024-06-05 - print number 9020a [A09020 Detail]

Download: New_York-2023-A09020-Amended.html

---

                STATE OF NEW YORK
        ________________________________________________________________________

                                         9020--A

                   IN ASSEMBLY

                                    February 5, 2024
                                       ___________

        Introduced  by M. of A. SOLAGES -- read once and referred to the Commit-
          tee on Health -- committee discharged, bill amended, ordered reprinted
          as amended and recommitted to said committee

        AN ACT to amend the public health law, in  relation  to  establishing  a
          blood  clot and pulmonary embolism policy workgroup; and providing for
          the repeal of such provisions upon expiration thereof

          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:

     1    Section 1. Section 206 of the public health law is amended by adding a
     2  new subdivision 32 to read as follows:
     3    32.  (a)  The  commissioner shall establish a blood clot and pulmonary
     4  embolism policy workgroup.  The workgroup shall be  composed  of  health
     5  care  providers,  patients  who  have  experienced  blood  clots, family
     6  members of patients who have died from blood clots, advocates, and other
     7  interested parties and associations. The governor, the temporary  presi-
     8  dent  of  the  senate and the speaker of the assembly shall each appoint
     9  two members to the workgroup.  The commissioner shall appoint the  chair
    10  of the workgroup.
    11    (b)  Members  of the workgroup shall receive no compensation for their
    12  services, but may be paid their actual and necessary  expenses  incurred
    13  in serving the workgroup.
    14    (c) It shall be the duty of the workgroup to study and issue recommen-
    15  dations  pertaining  to  the  incidence and treatment of blood clots and
    16  pulmonary embolisms within the state. The workgroup shall:
    17    (i) Identify the aggregate number of people who experience blood clots
    18  and pulmonary embolisms each year in this state.
    19    (ii) Identify how data is collected regarding blood  clots,  pulmonary
    20  embolisms, and adverse health outcomes associated with these conditions.
    21    (iii)  Identify  how  blood  clots  and pulmonary embolisms impact the
    22  lives of people in this state.
    23    (iv) Identify the standards  of  care  for  blood  clot  surveillance,
    24  detection, and treatment.
    25    (v)  Identify emerging treatments, therapies, and research relating to
    26  blood clots.

         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD13187-03-4
        A. 9020--A                          2

     1    (vi) Develop a risk surveillance system to help health care  providers
     2  identify patients who may be at a higher risk of forming blood clots and
     3  pulmonary embolisms.
     4    (vii) Develop policy recommendations to help improve patient awareness
     5  of blood clot risks.
     6    (viii) Develop policy recommendations to help improve surveillance and
     7  detection of patients who may be at a higher risk of forming blood clots
     8  in  licensed health care facilities, including hospitals, nursing homes,
     9  assisted living facilities, residential treatment facilities, and  ambu-
    10  latory surgical centers.
    11    (ix)  Develop  policy recommendations relating to guidelines used that
    12  affect the standard of care for patients at risk of forming blood clots.
    13    (x) Develop policy recommendations relating to providing patients  and
    14  their  families  with written notice of increased risks of forming blood
    15  clots.
    16    (d) The chair is authorized  to  create  subcommittees  to  help  with
    17  research,  scheduling  speakers  on  important  subjects, and drafting a
    18  workgroup report and policy recommendations.
    19    (e) No later than one year after the effective date of  this  subdivi-
    20  sion,  the  workgroup shall submit their recommendations in the form  of
    21  a written report to the commissioner, the speaker of the  assembly,  the
    22  temporary president of  the senate, the minority leader of the  assembly
    23  and the minority leader of the senate.
    24    (f) Upon receipt of the  workgroup's  report, the  commissioner  shall
    25  publish such recommendations on the department's website.
    26    §  2.  This  act shall take effect on the ninetieth day after it shall
    27  have become a law and shall expire and be deemed repealed two years  and
    28  ninety days after it shall have become a law.